Latest: FDA Approves New Biosimilar for Oncology Treatment
Oncology

EPCORE FL-1 Results Show Significance of Epcoritamab Combo in Follicular Lymphoma

by Cancer Network
0 Comments
0 Mins
The primary end points of the EPCORE FL-1 trial were met while assessing an epcoritamab-based combination for patients with R/R follicular lymphoma.
Tags:
Cancer Network
Author

Cancer Network

Previous Post
BMA demands Government intervention over ‘unaffordable’ GP premises charges
Next Post
The Window of Opportunity: Why Early Biologic Use Matters for Patients With Hidradenitis Suppurativa
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago